JEFFREY LE: Open Payments
NPI 1760152169 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$823 in 26 payments from 12 companies in 2025. Trend: 2023 $1,008 · 2024 $870 · 2025 $823
Food & beverage: $778Education: $45
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $171 |
| SOBI, INC | 4 | $139 |
| Syndax Pharmaceuticals, Inc. | 4 | $123 |
| AstraZeneca Pharmaceuticals LP | 3 | $98 |
| Incyte Corporation | 3 | $88 |
| JAZZ PHARMACEUTICALS INC. | 1 | $60 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Teleflex LLC | 1 | $24 |
Products named: Vonjo, CALQUENCE, Cresemba, JAKAFI, DEFITELIO, INQOVI, Xospata, SCEMBLIX.
Industry payments across TX — which companies pay providers there.
